India awaits WHO information on any cough syrup link to Gambia deaths

NEW DELHI, Oct 6 (Reuters) - India is awaiting more information from the World Health Organization on any links between an Indian-made cough syrup and the deaths of dozens of children in Gambia, two Indian officials said on Thursday.

The deaths of 66 children in the West African country is a blow to India's image as a "pharmacy of the world" that supplies medicines to all continents, especially Africa. The cough syrup was made by New Delhi-based Maiden Pharmaceuticals, the WHO said.

"Urgent investigation in the matter has been already taken up ... immediately . . .